Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study

Ophthalmology

Volumn 111, Issue 9, 2004, Pages 1627-1635

  Nouri Mahdavi, Kouros ^a   Hoffman, Douglas ^a   Coleman, Anne L ^a   Liu, Gang ^b   Li, Gang ^b   Gaasterland, Douglas ^c   Caprioli, Joseph ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Univ Ophthal Consult Washington   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DETERMINATION; AGED; ARTICLE; CATARACT EXTRACTION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SENSITIVITY ANALYSIS; VISUAL FIELD; DISEASE COURSE; MIDDLE AGED; MULTICENTER STUDY; OPEN ANGLE GLAUCOMA; OPTIC NERVE DISEASE; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; REGRESSION ANALYSIS; VISUAL DISORDER;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OPTIC NERVE DISEASES; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; VISION DISORDERS; VISUAL FIELDS;

EID: 4444335507     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2004.02.017     Document Type: Article

References (45)

1. Werner E.B., Drance S.M., Schulzer M. Trabeculectomy and the progression of glaucomatous visual field loss. Arch Ophthalmol. 95:1977;1374-1377
2. The Advanced Glaucoma Intervention Study (AGIS): 1. Study design and methods and baseline characteristics of study patients. Control Clin Trials 1994;15:299-325
3. Advanced Glaucoma Intervention Study. 2. Visual field test scoring and reliability. Ophthalmology 1994;101:1445-55
4. Gardiner S.K., Crabb D.P. Examination of different pointwise linear regression methods for determining visual field progression. Invest Ophthalmol Vis Sci. 43:2002;1400-1407
5. Noureddin B.N., Poinoosawmy D., Fietzke F.W., Hitchings R.A. Regression analysis of visual-field progression in low tension glaucoma. Br J Ophthalmol. 75:1991;493-495
6. Membrey W.L., Poinoosawmy D.P., Bunce C., et al. Comparison of visual field progression in patients with normal pressure glaucoma between eyes with and without visual field loss that threatens fixation. Br J Ophthalmol. 84:2000;1154-1158
7. Membrey W.L., Bunce C., Poinoosawmy D.P., et al. Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma 2. Visual field progression. Br J Ophthalmol. 85:2001;696-701
8. Chen P.P. Correlation of visual field progression between eyes in patients with open-angle glaucoma. Ophthalmology. 109:2002;2093-2099
9. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS) 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 130:2000;429-440
10. Katz J., Congdon N., Friedman D.S. Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment. Arch Ophthalmol. 117:1999;1137-1142
11. Katz J. Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment. Ophthalmology. 106:1999;391-395
12. Vesti E., Johnson C.A., Chauhan B.C. Comparison of different methods for detecting glaucomatous visual field progression. Invest Ophthalmol Vis Sci. 44:2003;3873-3879
13. Katz J., Gilbert D., Quigley H.A., Sommer A. Estimating progression of visual field loss in glaucoma. Ophthalmology. 104:1997;1017-1025
14. Spry P.G., Bates A.B., Johnson C.A., Chauhan B.C. Simulation of longitudinal threshold visual field data. Invest Ophthalmol Vis Sci. 41:2000;2192-2200
15. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS) 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol. 134:2002;499-512
16. Armaly M.F., Krueger D.E., Maunder L., et al. Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects. Arch Ophthalmol. 98:1980;2163-2171
17. Mao L.K., Stewart W.C., Shields M.B. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthalmol. 111:1991;51-55
18. Stewart W.C., Kolker A.E., Sharpe E.D., et al. Factors associated with long-term progression or stability in primary open-angle glaucoma. Am J Ophthalmol. 130:2000;274-279
19. Lichter P.R., Musch D.C., Gillespie B.W., et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 108:2001;1943-1953
20. Landers J., Goldberg I., Graham S.L. Analysis of risk factors that may be associated with progression from ocular hypertension to primary open angle glaucoma. Clin Experiment Ophthalmol. 30:2002;242-247
21. Leske M.C., Heijl A., Hussein M., et al. Factors for glaucoma progression and the effect of treatment the Early Manifest Glaucoma Trial. Arch Ophthalmol. 121:2003;48-56
22. Nouri-Mahdavi K, Coleman AL, Hoffman D, et al. Pointwise linear regression for evaluation of visual field outcomes and comparison to the AGIS methodology. Arch Ophthalmol. In press
23. The Advanced Glaucoma Intervention Study. Manual of Operations, 1993. Accession no. PB93-220192. Springfield, VA: National Technical Information Service; 1993
24. SPSS [computer program]. Version 11.5. Chicago: SPSS Inc.; 2003
25. SAS [computer program]. Version 8.2. Cary, NC: SAS Institute; 2001
26. Wilson R., Walker A.M., Dueker D.K., Crick R.P. Risk factors for rate of progression of glaucomatous visual field loss a computer-based analysis. Arch Ophthalmol. 100:1982;737-741
27. Tezel G., Siegmund K.D., Trinkaus K., et al. Clinical factors associated with progression of glaucomatous optic disc damage in treated patients. Arch Ophthalmol. 119:2001;813-818
28. Collaborative Normal-Tension Glaucoma Study Group, Drance S., Anderson D.R., Schulzer M. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol. 131:2001;699-708
29. Niesel P., Flammer J. Correlations between intraocular pressure, visual field and visual acuity, based on 11 years of observations of treated chronic glaucomas. Int Ophthalmol. 3:1980;31-35
30. O'Brien C., Schwartz B., Takamoto T., Wu D.C. Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma. Am J Ophthalmol. 111:1991;491-500
31. Stewart W.C., Chorak R.P., Hunt H.H., Sethuraman G. Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head. Am J Ophthalmol. 116:1993;176-181
32. Bergea B., Bodin L., Svedbergh B. Impact of intraocular pressure regulation on visual fields in open-angle glaucoma. Ophthalmology. 106:1999;997-1004., discussion 1004-5
33. Asrani S., Zeimer R., Wilensky J., et al. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma. 9:2000;134-142
34. Gardiner S.K., Crabb D.P. Frequency of testing for detecting visual field progression. Br J Ophthalmol. 86:2002;560-564
35. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 126:1998;487-497
36. Vogel R., Crick R.P., Newson R.B., et al. Association between intraocular pressure and loss of visual field in chronic simple glaucoma. Br J Ophthalmol. 74:1990;3-6
37. Schulzer M., Drance S.M., Douglas G.R. A comparison of treated and untreated glaucoma suspects. Ophthalmology. 98:1991;301-307
38. Martinez-Bello C., Chauhan B.C., Nicolela M.T., et al. Intraocular pressure and progression of glaucomatous visual field loss. Am J Ophthalmol. 129:2000;302-308
39. Oliver J.E., Hattenhauer M.G., Herman D., et al. Blindness and glaucoma a comparison of patients progressing to blindness from glaucoma with patients maintaining vision. Am J Ophthalmol. 133:2002;764-772
40. Palmberg P. Risk factors for glaucoma progression where does intraocular pressure fit in? Arch Ophthalmol. 119:2001;897-898
41. Holmin C., Krakau C.E. Trabeculoplasty and visual field decay a follow-up study using computerized perimetry. Curr Eye Res. 3:1984;1101-1105
42. Suzuki Y., Shirato S., Adachi M., Hamada C. Risk factors for the progression of treated primary open-angle glaucoma a multivariate life-table analysis. Graefes Arch Clin Exp Ophthalmol. 237:1999;463-467
43. Grant W.M., Burke J.F. Jr. Why do some people go blind from glaucoma? Ophthalmology. 89:1982;991-998
44. Wilson M.R., Kosoko O., Cowan C.L. Jr, et al. Progression of visual field loss in untreated glaucoma patients and glaucoma suspects in St. Lucia, West Indies. Am J Ophthalmol. 134:2002;399-405
45. Ocular Hypertension Treatment Study Group, Gordon M.O., Beiser J.A., Brandt J.D., et al. The Ocular Hypertension Treatment Study baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 120:2002;714-720., discussion 829-30